Primary liver cancer,often referred to as hepatocellular carcinoma(HCC),is the fourth most common malignant tumor and the second leading cause of cancer-related deaths in China[1].Each year,39.0%-53.6%of newly diagnos...Primary liver cancer,often referred to as hepatocellular carcinoma(HCC),is the fourth most common malignant tumor and the second leading cause of cancer-related deaths in China[1].Each year,39.0%-53.6%of newly diagnosed liver cancer are identified at an advanced stage,marked by short survival and a refractory clinical condition[2].However,current guidelines for diagnosing and treating liver cancer broadly classify the advanced stage,advocating a singular strategy without considering individual patient treatment options.Therefore,it is urgent to establish a comprehensive and practical expert consensus specifically for China to enhance early diagnosis and treatment of liver cancer.Using the Delphi method,an expert team has,for the first time,refined the classification criteria for Chinese liver cancer patients and developed corresponding optimal treatment regimen recommendations[3].This consensus is intended to provide a more detailed,scientific,and reasonable reference basis for the selection of individualized diagnosis and treatment plans.展开更多
基金funded by the National Natural Science Foundation of China(grant number:82272956)Beijing Municipal Science&Technology(No.Z231100004823030).
文摘Primary liver cancer,often referred to as hepatocellular carcinoma(HCC),is the fourth most common malignant tumor and the second leading cause of cancer-related deaths in China[1].Each year,39.0%-53.6%of newly diagnosed liver cancer are identified at an advanced stage,marked by short survival and a refractory clinical condition[2].However,current guidelines for diagnosing and treating liver cancer broadly classify the advanced stage,advocating a singular strategy without considering individual patient treatment options.Therefore,it is urgent to establish a comprehensive and practical expert consensus specifically for China to enhance early diagnosis and treatment of liver cancer.Using the Delphi method,an expert team has,for the first time,refined the classification criteria for Chinese liver cancer patients and developed corresponding optimal treatment regimen recommendations[3].This consensus is intended to provide a more detailed,scientific,and reasonable reference basis for the selection of individualized diagnosis and treatment plans.
